Yes, Philips Respironics agreed to a $1.1 billion settlement to resolve lawsuits from users of defective CPAP machines that released toxic foam particles into the airways of millions of people. The settlement was announced on April 29, 2024, and includes both compensation for personal injuries and medical monitoring. If you used a recalled Philips CPAP, BiPAP, or mechanical ventilator device, you may be eligible to claim money—though the claim deadline of January 31, 2025, has already passed, which creates significant challenges for new claimants. This article explains the settlement structure, how much different cases are worth, what injuries qualify, and what the current status is as of March 2026.
In June 2021, Philips recalled approximately 3.5 million sleep apnea devices worldwide after discovering that the PE-PUR polyurethane foam used for sound dampening was degrading and releasing harmful particles. Users who inhaled these particles reported lung cancer, respiratory illnesses, inflammatory diseases, and other serious health complications. The FDA received over 105,000 medical device reports related to the defect, with 385 deaths attributed to the degraded foam as of June 2023. This became one of the largest medical device settlements in U.S. history.
Table of Contents
- What Is the Philips CPAP Recall and Why Did It Happen?
- How Much Compensation Is Available Under the Settlement?
- What Injuries and Damages Are Covered by the Settlement?
- How Do I File a Claim and What Should I Expect?
- What Medical Evidence Do You Need to Support Your Claim?
- Current Status of the Settlement as of March 2026
- What If You Missed the Claim Deadline or Have Questions?
What Is the Philips CPAP Recall and Why Did It Happen?
The recall affects Philips Respironics DreamStation and other sleep apnea devices produced before April 2021. The root cause was the PE-PUR polyurethane foam that Philips used as a sound-dampening material inside the devices. Over time, especially in humid environments like bathrooms and bedrooms with air humidifiers, this foam deteriorated into small particles and released degradation byproducts. Users with the devices set to continuous operation overnight inhaled these particles directly into their lungs every night for months or years before the recall was announced. The particles themselves are hazardous, but so are the chemical byproducts released during foam breakdown. FDA investigations linked this exposure to increased rates of cancer, asthma exacerbation, pulmonary fibrosis, and other serious respiratory and systemic diseases.
For example, a 65-year-old man who used a Philips DreamStation for five years before the recall was announced was later diagnosed with stage 3 lung cancer. He had no smoking history and no genetic predisposition to cancer. His case is one of hundreds where users developed cancer within two to five years of using the defective device. Philips initially told customers to simply stop using the devices, but offered little guidance on testing or remediation. The company took years to develop and deploy replacement devices, leaving many patients without CPAP therapy during that gap. Some patients’ sleep apnea went untreated, increasing their stroke and heart attack risk, while others struggled to find compatible alternative devices covered by insurance.
How Much Compensation Is Available Under the Settlement?
The $1.1 billion settlement is divided into several distinct categories. The primary personal injury fund contains $1.075 billion to compensate people who suffered serious health complications or death. A separate $25 million fund covers medical monitoring—ongoing doctor visits and tests to screen for future complications in people exposed to the foam but who haven’t yet developed diagnosed illnesses. On top of this, a separate class-action settlement of $479 million was established to reimburse people for the cost of purchasing or leasing the defective devices themselves. Additionally, Philips set aside another $630 million to address growing CPAP lawsuit claims, bringing the total potential recovery to over $2 billion. Actual payout amounts vary dramatically based on the severity of the injury and the strength of the medical evidence.
For less severe injuries—such as resolved respiratory infections, temporary breathing problems, or minor inflammatory conditions with no lasting damage—claimants typically receive between $7,500 and $10,000. For moderate injuries like asthma exacerbation or chronic bronchitis that requires ongoing treatment, payouts range from $15,000 to $50,000. For the most serious cases—including lung cancer diagnosis, significant pulmonary fibrosis, organ damage, or cases resulting in death—settlements can exceed $100,000, with some reaching $200,000 or more. However, the settlement fund has limits. If a very large number of severe claims are approved, the compensation per claimant may be reduced proportionally. This is why early claims filed before the January 31, 2025 deadline have a financial advantage—they are more likely to receive the full amount claimed rather than a percentage reduction if the fund becomes oversubscribed.
What Injuries and Damages Are Covered by the Settlement?
The settlement covers a broad range of health complications linked to the foam degradation. These include diagnosed cancers (especially lung cancer, but also bladder, kidney, and other malignancies), serious respiratory diseases like pulmonary fibrosis and interstitial lung disease, inflammatory conditions such as sarcoidosis, asthma exacerbation beyond the person’s baseline, chronic obstructive pulmonary disease (COPD) development, severe infections or pneumonia, organ damage from systemic inflammation, and death. The settlement explicitly includes cases where the foam exposure is a significant contributing factor, even if other risk factors exist.
For example, a 58-year-old woman with mild asthma who used a Philips DreamStation from 2016 to 2021 and subsequently developed severe asthma requiring biological therapeutics and frequent emergency room visits would be eligible. Another example: a 72-year-old man diagnosed with idiopathic pulmonary fibrosis who had been using the device for seven years before the recall would likely qualify, especially if medical experts can testify that the foam exposure accelerated his lung disease progression. The settlement also covers derivative claims from family members of deceased users. If someone died and the foam exposure was a contributing factor, their estate or surviving family members can potentially recover compensation for wrongful death, medical expenses, and loss of companionship.
How Do I File a Claim and What Should I Expect?
The official claims process is managed through the settlement administrator. The claim deadline was January 31, 2025—which has now passed. This is a hard deadline, and very few exceptions have been granted. If you did not file by that date, your opportunity to claim from the personal injury fund is effectively closed. Some claimants with exceptional circumstances may have sought court extensions, but these are extremely rare and require demonstrating that they had legitimate reasons for missing the deadline, such as incapacity, lack of notice, or medical emergency. For those who did file by the January 31, 2025 deadline, the next steps involve submitting medical documentation to support the claim. The claims administrator reviews the evidence and determines the injury category.
Once approved, claimants typically receive payment within 90 to 180 days. Payouts have been ongoing since 2025. The settlement still requires final federal court approval, which is expected but not yet finalized as of March 2026. Until court approval is official, there remains a small theoretical risk that the terms could change, though this is unlikely. If you missed the January 31, 2025 deadline, your only option is to pursue an individual lawsuit. However, this is significantly more expensive and time-consuming. You would need to hire an attorney, pay court fees, gather medical evidence, and potentially wait years for trial. Individual lawsuits against Philips for CPAP injuries are still possible, and there are 619 pending cases in the multidistrict litigation (MDL 3014) as of March 2026, but these cases proceed much more slowly and with no guarantee of settlement amounts.
What Medical Evidence Do You Need to Support Your Claim?
To successfully claim from the settlement, you must provide medical documentation proving both that you used the recalled device and that you developed a recognized injury. The claims administrator requires medical records from your healthcare providers showing diagnosis dates, treatment details, and any specialist consultations. For cancer claims, you’ll need pathology reports and oncology records. For lung disease claims, you’ll need pulmonary function tests (PFTs), CT scans, and pulmonologist evaluations. For death claims, you need the death certificate and medical records showing the device use and injury.
One major limitation is that many people cannot prove they used the specific recalled serial number of device because they no longer have the device, the serial number label has worn off, or they disposed of it years ago. In these cases, you can submit proof of purchase, pharmacy records, insurance claims, or testimony from family members. However, without device verification, some claims are denied or assigned lower compensation because causation is harder to establish. Another challenge: if you were diagnosed with a condition like asthma or COPD before you even purchased the Philips device, the settlement administrator may argue that the device didn’t cause the disease, only potentially worsened it. In such cases, you’ll need medical expert testimony showing that the device exposure significantly accelerated your disease progression.
Current Status of the Settlement as of March 2026
As of March 2026, the settlement is still in process, with 619 pending cases remaining in MDL 3014, which is coordinated in the Western District of Pennsylvania federal court. The settlement agreement has been reached, and payments to approved claimants began in 2025. However, the settlement still requires formal federal court approval, which is the final step before it becomes fully binding. This approval is expected but has not yet been officially entered as of this writing.
For claimants who already submitted claims before the January 31, 2025 deadline and were approved, payments have been distributed. Those with severe injuries have received the highest amounts. The claims administrator is still processing some remaining cases and verifying medical documentation. If you filed a claim and have not yet received payment, the administrator’s website (respironicspisettlement.com) provides case status updates.
What If You Missed the Claim Deadline or Have Questions?
If you missed the January 31, 2025 claim deadline, your path forward depends on whether you are willing to pursue litigation. The MDL 3014 in Pennsylvania’s federal court is still accepting new cases, and plaintiffs can join that litigation to pursue individual claims. However, without the settlement structure, these cases have longer timelines and more uncertainty regarding payout amounts.
An attorney specializing in personal injury or medical device litigation can evaluate whether your claim has merit and advise on costs. Going forward, the Philips case serves as a reminder of the importance of monitoring FDA recalls and acting quickly. If you or a family member was affected by the CPAP recall and believe you have a valid claim, contact the official settlement website at respironicspisettlement.com to verify your status or explore litigation options with an attorney before any additional statutes of limitation expire.